Convolutional neural networks quantify antibiotic resistance in Mycobacterium tuberculosis with diagnostic grade accuracy and predict treatment response

2026-04-24 · Source: Machine learning : nature.com subject feeds · Field: Health & Wellbeing — Pharmaceuticals & Biotechnology, Clinical Care & Medical Practice, Medical Devices & Health Technology · Depth: Expert, medium

Summary

Convolutional neural networks (CNNs) have been developed to predict minimum inhibitory concentrations (MICs) for eight antibiotics from *Mycobacterium tuberculosis* complex (MTBC) gene sequences. These CNN models achieve diagnostic-grade accuracy, predicting 89% of MICs within one drug concentration doubling. The models incorporate evolutionary information, protein biochemical properties, and data augmentation for rare variants. Despite being trained on less than 52% of the World Health Organization's (WHO) MTBC drug resistance mutation catalog data, the CNNs accurately predict the effects of 97% of the catalog's graded mutations. Furthermore, in a cohort of 373 patients with rifampicin-susceptible *M. tuberculosis* infections, higher CNN-predicted rifampicin MICs correlated with unfavorable treatment outcomes, indicating the clinical relevance of subtle MIC differences below the resistance threshold.

Key takeaway

For AI Scientists and Research Scientists developing diagnostic tools for infectious diseases, this work demonstrates that integrating diverse biological data dimensions (evolutionary, biochemical) into machine learning models can achieve clinical-grade accuracy. You should consider these multi-modal data inputs and data augmentation strategies to enhance model performance, especially for predicting continuous biomedical variables like MICs, which can inform treatment decisions even below traditional resistance thresholds.

Key insights

CNNs can predict antibiotic MICs from genomic data with clinical accuracy, leveraging diverse biological features.

Principles

• Integrate evolutionary and biochemical data for robust ML.
• Data augmentation improves rare variant prediction.
• Subtle MIC variations impact treatment outcomes.

Method

Convolutional neural networks predict MICs from MTBC gene sequences by encoding evolutionary information, protein biochemical properties, and using data augmentation for rare variants.

In practice

• Use genomic data for drug resistance prediction.
• Augment rare variant data in ML training.
• Consider subtle MIC shifts in treatment planning.

Topics

• Convolutional Neural Networks
• Mycobacterium tuberculosis
• Antibiotic Resistance
• Minimum Inhibitory Concentrations
• Genomic Data

Best for: AI Scientist, Research Scientist

Related on AIssential

• Using AI to outsmart drug-resistant bacteria — AI tools significantly accelerate antibiotic discovery by identifying non-intuitive biological patterns and generating novel therapeutic ideas.
• Predicting and interpreting cell-type-specific drug responses in the small-data regime using inductive priors — PrePR-CT uses graph-based deep learning with cell-type-specific co-expression networks to predict drug responses in data-limited settings.
• Benchmarking Machine Learning Architectures for Antimicrobial Stewardship in Pediatric ICUs — Machine learning performance for pediatric antimicrobial stewardship is driven more by target design and data characteristics than model complexity.
• Hybrid deep learning model for multimodal vocal and lung signal analysis in health monitoring — A hybrid deep learning model effectively integrates vocal and lung signal analysis for accurate disease detection.
• 🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik — Improving cancer drug success requires advanced AI models for precise patient selection based on multimodal biological data.
• Machine Learning-Based Pre-Test Risk Stratification for PCR-Confirmed Chlamydia Using Patient-Reported Data and Urine Biomarkers — Urine biomarkers offer a reliable, consistent signal for Chlamydia pre-test risk stratification, complementing patient-reported data.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.